サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：米国の外来外科センター (ASC) 市場 (2023年～2032年)：市場規模 (所有区分・手術タイプ・専門分野・サービス別)・成長の潜在性・競合市場シェア・予測
市場調査レポート
商品コード
1161815

米国の外来外科センター (ASC) 市場 (2023年～2032年)：市場規模 (所有区分・手術タイプ・専門分野・サービス別)・成長の潜在性・競合市場シェア・予測

U.S. Ambulatory Surgical Centers Market Size By Ownership, By Surgery Type, By Specialty Type, By Service, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 103 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
米国の外来外科センター (ASC) 市場 (2023年～2032年)：市場規模 (所有区分・手術タイプ・専門分野・サービス別)・成長の潜在性・競合市場シェア・予測
出版日: 2022年11月18日
発行: Global Market Insights Inc.
ページ情報: 英文 103 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の外来外科センター (ASC) の市場は、低侵襲治療の普及により、2032年にかけて積極的に成長すると予想されています。

また、有利な診療報酬や政府の政策、ヘルスケア支出の急増、患者中心のヘルスケア実践への需要の高まり、人口の高齢化、などの要因も市場成長を推進する見通しです。

所有区分別で見る地、医師の部門が2022年に215億米ドル超を示しています。同部門の成長は、低価格の治療に対する高い需要に起因していると考えられています。一方、企業部門は2032年末にかけて高い収益規模を示すと予測されています。ASCでの外科治療の促進のため、公的機関や民間団体が資金調達や意識改革を進めていることから、同部門への大規模な投資が行われており、成長が見込まれています。

当レポートでは、米国の外来外科センター (ASC) の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、イノベーション・持続可能性の情勢、市場規模の推移・予測、各種区分・主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 米国の外来外科センター (ASC) 産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 促進要因
    • 潜在的リスク＆課題
  • 成長性分析
  • COVID-19：影響分析
  • ポーターの分析
  • 競合情勢
  • PESTLE分析

第4章 米国の外来外科センター (ASC) 市場：所有区分別

  • 主要動向
  • 医師
  • 病院
  • 企業
  • 医師・病院
  • 医師・企業
  • 病院・企業

第5章 米国の外来外科センター (ASC) 市場：手術タイプ別

  • 主要動向
  • 歯科
  • 耳鼻科
  • 内視鏡検査
  • 産婦人科
  • 眼科
  • 整形外科
  • 心臓血管
  • 神経
  • 形成外科
  • 足病
  • その他

第6章 米国の外来外科センター (ASC) 市場：専門分野別

  • 主要動向
  • 多分野
  • 単分野

第7章 米国の外来外科センター (ASC) 市場：サービス別

  • 主要動向
  • 診断
  • 治療

第8章 企業プロファイル

  • 戦略ダッシュボード
  • Ambulatory Surgical Center of America
  • AMSURG（Kohlberg Kravis Roberts & Co L P）
  • ASD Management
  • Elite surgical affiliates（Nobilis Health Corp.）
  • HCA Healthcare
  • Medical Facilities Corporation
  • Physicians Endoscopy
  • Pinnacle III
  • Proliance Surgeons
  • Regent Surgical Health
  • Surgery Partners
  • SurgCenter Development
  • SCA Health（Unitedhealth Group Incorporated）
  • Surgical Management Professionals
  • Tenet Health
図表

Data Tables

  • TABLE 1 U.S. ambulatory surgical centers industry 360 degree synopsis, 2018 - 2032
  • TABLE 2 U.S. ambulatory surgical centers market, 2018 - 2024 (USD Million)
  • TABLE 3 U.S. ambulatory surgical centers market, 2025 - 2032 (USD Million)
  • TABLE 4 U.S. ambulatory surgical centers market, by ownership, 2018 - 2024 (USD Million)
  • TABLE 5 U.S. ambulatory surgical centers market, by ownership, 2025 - 2032 (USD Million)
  • TABLE 6 U.S. ambulatory surgical centers market, by surgery type, 2018 - 2024 (USD Million)
  • TABLE 7 U.S. ambulatory surgical centers market, by surgery type, 2025 - 2032 (USD Million)
  • TABLE 8 U.S. ambulatory surgical centers market, by specialty type, 2018 - 2024 (USD Million)
  • TABLE 9 U.S. ambulatory surgical centers market, by specialty type, 2025 - 2032 (USD Million)
  • TABLE 10 U.S. ambulatory surgical centers market, by service, 2018 - 2024 (USD Million)
  • TABLE 11 U.S. ambulatory surgical centers market, by service, 2025 - 2032 (USD Million)
  • TABLE 12 Industry impact forces
  • TABLE 13 Physician only market size, 2018 - 2024 (USD Million)
  • TABLE 14 Physician only market size, 2025 - 2032 (USD Million)
  • TABLE 15 Hospital only market size, 2018 - 2024 (USD Million)
  • TABLE 16 Hospital only market size, 2025 - 2032 (USD Million)
  • TABLE 17 Corporation only market size, 2018 - 2024 (USD Million)
  • TABLE 18 Corporation only market size, 2025 - 2032 (USD Million)
  • TABLE 19 Physician & hospital market size, 2018 - 2024 (USD Million)
  • TABLE 20 Physician & hospital market size, 2025 - 2032 (USD Million)
  • TABLE 21 Physician & corporation market size, 2018 - 2024 (USD Million)
  • TABLE 22 Physician & corporation market size, 2025 - 2032 (USD Million)
  • TABLE 23 Hospital & corporation market size, 2018 - 2024 (USD Million)
  • TABLE 24 Hospital & corporation market size, 2025 - 2032 (USD Million)
  • TABLE 25 Dental market size, 2018 - 2024 (USD Million)
  • TABLE 26 Dental market size, 2025 - 2032 (USD Million)
  • TABLE 27 Otolaryngology market size, 2018 - 2024 (USD Million)
  • TABLE 28 Otolaryngology market size, 2025 - 2032 (USD Million)
  • TABLE 29 Endoscopy market size, 2018 - 2024 (USD Million)
  • TABLE 30 Endoscopy market size, 2025 - 2032 (USD Million)
  • TABLE 31 Obstetrics/gynecology market size, 2018 - 2024 (USD Million)
  • TABLE 32 Obstetrics/gynecology market size, 2025 - 2032 (USD Million)
  • TABLE 33 Ophthalmology market size, 2018 - 2024 (USD Million)
  • TABLE 34 Ophthalmology market size, 2025 - 2032 (USD Million)
  • TABLE 35 Orthopedic market size, 2018 - 2024 (USD Million)
  • TABLE 36 Orthopedic market size, 2025 - 2032 (USD Million)
  • TABLE 37 Cardiovascular market size, 2018 - 2024 (USD Million)
  • TABLE 38 Cardiovascular market size, 2025 - 2032 (USD Million)
  • TABLE 39 Neurology market size, 2018 - 2024 (USD Million)
  • TABLE 40 Neurology market size, 2025 - 2032 (USD Million)
  • TABLE 41 Plastic surgery market size, 2018 - 2024 (USD Million)
  • TABLE 42 Plastic surgery market size, 2025 - 2032 (USD Million)
  • TABLE 43 Podiatry market size, 2018 - 2024 (USD Million)
  • TABLE 44 Podiatry market size, 2025 - 2032 (USD Million)
  • TABLE 45 Others market size, 2018 - 2024 (USD Million)
  • TABLE 46 Others market size, 2025 - 2032 (USD Million)
  • TABLE 47 Single specialty market size, 2018 - 2024 (USD Million)
  • TABLE 48 Single specialty market size, 2025 - 2032 (USD Million)
  • TABLE 49 Multi-specialty market size, 2018 - 2024 (USD Million)
  • TABLE 50 Multi-specialty market size, 2025 - 2032 (USD Million)
  • TABLE 51 Diagnosis market size, 2018 - 2024 (USD Million)
  • TABLE 52 Diagnosis market size, 2025 - 2032 (USD Million)
  • TABLE 53 Treatment market size, 2018 - 2024 (USD Million)
  • TABLE 54 Treatment market size, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Data validation
  • FIG. 3 U.S. ambulatory surgical centers industry 360 degree synopsis, 2018 - 2032
  • FIG. 4 Industry segmentation
  • FIG. 5 U.S. ambulatory surgical centers market, 2018 - 2032 (USD million)
  • FIG. 6 Growth potential analysis, by ownership
  • FIG. 7 Growth potential analysis, by surgery type
  • FIG. 8 Growth potential analysis, by specialty type
  • FIG. 9 Growth potential analysis, by service
  • FIG. 10 Porter's analysis
  • FIG. 11 Company matrix analysis
  • FIG. 12 PESTLE analysis
  • FIG. 13 Key segment trends, by ownership, 2022
  • FIG. 14 Key segment trends, by surgery type, 2022
  • FIG. 15 Key segment trends, by specialty type, 2022
  • FIG. 16 Key segment trends, by service, 2022
  • FIG. 17 Strategy dashboard, 2021
目次
Product Code: 4520

U.S. ambulatory surgical centers (ASCs) market is expected to grow positively through 2032 owing to the availability of minimally invasive treatments. In addition, promising reimbursements as well as government policies are also expected to boost the industry growth.

The U.S. market for ambulatory surgical centers is anticipated to expand continuously as a result of the exponential rise in healthcare spending and surging demand for patient-centered healthcare practices. The market valuation will also be fueled by an aging population, favorable reimbursements, chronic diseases, and government initiatives. The benefits of minimally invasive procedures also influence patients' preference for ASCs.

Leading behemoths in U.S. ambulatory surgical centers market are relentlessly working toward new launches, innovations, and facility development. For instance, in January 2021, SurgCenter Development (SCD) announced the development of Advanced Surgical Care of Maryland. Both outpatient orthopedic surgery and pain management are likely to be offered at the new surgical location. Such trends are expected to propel the market outlook.

The U.S. ambulatory surgical centers industry has been categorized in terms of ownership, surgery type, specialty type, and service.

Based on ownership, the physician-only segment was valued at more than $21.5 billion in 2022. The strong segmental growth of physician-only ASCs can be ascribed to the high demand for affordable treatments. Meanwhile, the corporation-only segment is anticipated to amass sizeable revenue by the end of 2032. Significant investments have been made in the corporation-only ASCs segment as a result of the growing funding and raising awareness initiatives by public and private bodies to promote surgical treatments at ASCs, fostering the industry growth.

With respect to surgery type, the endoscopy segment held over 15% market share in 2022. The increasing number of aging populations that is particularly prone to various diseases is likely to boost market growth through the forecast period. Elderly patients frequently struggle with financial burden; hence ASCs are frequently favored by this patient population because they are more affordable than hospitals.

In terms of specialty, the single specialty segment is projected to garner steady growth over the research timeline fueled by the increase of ambulatory surgery centers with a single specialty. Additionally, cost-effectiveness, reduced chances of physical attrition, and a huge number of facilities with single specializations are likely to promote the industry growth during 2023-2032.

On the basis of service, the diagnosis segment is subjected to expand notably through the forthcoming years credited to the surging public awareness regarding early disease diagnosis. Besides, availability of advanced technologies for early disease detection and quality care at low cost offered at ASCs would further complement the industry progression.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 U.S. ambulatory surgical centers industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Ownership trends
    • 2.1.3 Surgery type trends
    • 2.1.4 Specialty type trends
    • 2.1.5 Service trends

Chapter 3 US Ambulatory Surgical Centers Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing geriatric population & chronic diseases
      • 3.3.1.2 Availability of minimally invasive treatments
      • 3.3.1.3 Favourable reimbursements and government policies
      • 3.3.1.4 Lower risk of infections in ASCs than hospitals
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High costs of medical devices
      • 3.3.2.2 Low physician-to-patient ratio
  • 3.4 Growth potential analysis
    • 3.4.1 By ownership
    • 3.4.2 By surgery type
    • 3.4.3 By specialty type
    • 3.4.4 By service
  • 3.5 COVID- 19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2022
    • 3.7.1 Company matrix analysis, 2022
  • 3.8 PESTLE analysis

Chapter 4 US Ambulatory Surgical Centers Market, By Ownership

  • 4.1 Key segment trends
  • 4.2 Physician only
    • 4.2.1 Market size, 2018 - 2032 (USD Million)
  • 4.3 Hospital only
    • 4.3.1 Market size, 2018 - 2032 (USD Million)
  • 4.4 Corporation only
    • 4.4.1 Market size, 2018 - 2032 (USD Million)
  • 4.5 Physician & hospital
    • 4.5.1 Market size, 2018 - 2032 (USD Million)
  • 4.6 Physician & corporation
    • 4.6.1 Market size, 2018 - 2032 (USD Million)
  • 4.7 Hospital & corporation
    • 4.7.1 Market size, 2018 - 2032 (USD Million)

Chapter 5 US Ambulatory Surgical Centers Market, By Surgery Type

  • 5.1 Key segment trends
  • 5.2 Dental
    • 5.2.1 Market size, 2018 - 2032 (USD Million)
  • 5.3 Otolaryngology
    • 5.3.1 Market size, 2018 - 2032 (USD Million)
  • 5.4 Endoscopy
    • 5.4.1 Market size, 2018 - 2032 (USD Million)
  • 5.5 Obstetrics/gynaecology
    • 5.5.1 Market size, 2018 - 2032 (USD Million)
  • 5.6 Ophthalmology
    • 5.6.1 Market size, 2018 - 2032 (USD Million)
  • 5.7 Orthopedic
    • 5.7.1 Market size, 2018 - 2032 (USD Million)
  • 5.8 Cardiovascular
    • 5.8.1 Market size, 2018 - 2032 (USD Million)
  • 5.9 Neurology
    • 5.9.1 Market size, 2018 - 2032 (USD Million)
  • 5.10 Plastic surgery
    • 5.10.1 Market size, 2018 - 2032 (USD Million)
  • 5.11 Podiatry
    • 5.11.1 Market size, 2018 - 2032 (USD Million)
  • 5.12 Others
    • 5.12.1 Market size, 2018 - 2032 (USD Million)

Chapter 6 US Ambulatory Surgical Centers Market, By Specialty Type

  • 6.1 Key segment trends
  • 6.2 Multi-specialty
    • 6.2.1 Market size, 2018 - 2032 (USD Million)
  • 6.3 Single specialty
    • 6.3.1 Market size, 2018 - 2032 (USD Million)

Chapter 7 US Ambulatory Surgical Centers Market, By Service

  • 7.1 Key segment trends
  • 7.2 Diagnosis
    • 7.2.1 Market size, 2018 - 2032 (USD Million)
  • 7.3 Treatment
    • 7.3.1 Market size, 2018 - 2032 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Strategy dashboard, 2022
  • 8.2 Ambulatory Surgical Center of America
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Service landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 Swot analysis
  • 8.3 AMSURG (Kohlberg Kravis Roberts & Co L P)
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Service landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 Swot analysis
  • 8.4 ASD Management
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Service landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 Swot analysis
  • 8.5 Elite surgical affiliates (Nobilis Health Corp.)
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Service landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 Swot analysis
  • 8.6 HCA Healthcare
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Service landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 Swot analysis
  • 8.7 Medical Facilities Corporation
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Service landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 Swot analysis
  • 8.8 Physicians Endoscopy
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Service landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 Swot analysis
  • 8.9 Pinnacle III
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Service landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 Swot analysis
  • 8.10 Proliance Surgeons
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Service landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 Swot analysis
  • 8.11 Regent Surgical Health
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Service landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 Swot analysis
  • 8.12 Surgery Partners
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Service landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 Swot analysis
  • 8.13 SurgCenter Development
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Service landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 Swot analysis
  • 8.14 SCA Health (Unitedhealth Group Incorporated)
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Service landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 Swot analysis
  • 8.15 Surgical Management Professionals
    • 8.15.1 Business overview
    • 8.15.2 Financial data
    • 8.15.3 Service landscape
    • 8.15.4 Strategic outlook
    • 8.15.5 Swot analysis
  • 8.16 Tenet Health
    • 8.16.1 Business overview
    • 8.16.2 Financial data
    • 8.16.3 Service landscape
    • 8.16.4 Strategic outlook
    • 8.16.5 Swot analysis